Danske Bank A S Takes Position in Ventas, Inc. $VTR

Key Points

• Danske Bank A/S initiated a position in Ventas during the second quarter, purchasing 246,402 shares valued at approximately $21.9 million. Institutional investors collectively own 94.18% of the healthcare REIT.
• Ventas reported quarterly earnings of $0.97 per share, exceeding estimates by $0.01, while revenue reached $1.73 billion—up 21.7% year over year and above expectations.
• Analyst sentiment remains positive, with 15 Buy ratings and three Holds producing a consensus “Moderate Buy” rating and an average price target of $98, compared with the stock’s reported price of $92.82.

Danske Bank A S bought a new position in shares of Ventas, Inc. (NYSE:VTR - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 246,402 shares of the real estate investment trust's stock, valued at approximately $21,880,000.

Several other large investors have also recently bought and sold shares of the company. NewEdge Advisors LLC raised its holdings in Ventas by 856.1% in the 1st quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust's stock valued at $545,000 after buying an additional 7,097 shares during the last quarter. Empowered Funds LLC raised its stake in shares of Ventas by 6.8% during the first quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust's stock valued at $576,000 after acquiring an additional 536 shares during the last quarter. Woodline Partners LP raised its stake in shares of Ventas by 46.8% during the first quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust's stock valued at $2,532,000 after acquiring an additional 11,739 shares during the last quarter. Focus Partners Wealth lifted its holdings in shares of Ventas by 130.4% during the first quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust's stock worth $1,486,000 after purchasing an additional 12,233 shares during the period. Finally, Gamco Investors INC. ET AL acquired a new position in shares of Ventas during the second quarter worth $805,000. 94.18% of the stock is currently owned by institutional investors.

Ventas Trading Up 1.1%

NYSE VTR opened at $92.82 on Friday. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86. The business has a 50 day moving average price of $91.18 and a 200-day moving average price of $87.04. Ventas, Inc. has a 52 week low of $66.38 and a 52 week high of $101.60. The company has a market cap of $47.61 billion, a price-to-earnings ratio of 171.89, a P/E/G ratio of 2.12 and a beta of 0.69.

Ventas (NYSE:VTR - Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share for the quarter, beating analysts' consensus estimates of $0.96 by $0.01. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The firm had revenue of $1.73 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period last year, the firm earned $0.87 earnings per share. The business's quarterly revenue was up 21.7% compared to the same quarter last year. As a group, equities analysts expect that Ventas, Inc. will post 3.89 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts recently issued reports on the company. Mizuho raised their target price on Ventas from $98.00 to $104.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 22nd. Barclays assumed coverage on Ventas in a research report on Tuesday, July 7th. They set an "equal weight" rating and a $99.00 price objective for the company. Jefferies Financial Group upped their target price on Ventas from $97.00 to $100.00 and gave the company a "buy" rating in a report on Tuesday, May 12th. UBS Group increased their target price on shares of Ventas from $85.00 to $93.00 and gave the company a "neutral" rating in a research report on Monday, May 4th. Finally, Raymond James Financial started coverage on shares of Ventas in a report on Tuesday, June 16th. They set an "outperform" rating and a $94.00 price target for the company. Fifteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $98.00.

Insiders Place Their Bets

In related news, Director Michael J. Embler acquired 2,500 shares of the company's stock in a transaction on Wednesday, June 3rd. The shares were acquired at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the purchase, the director owned 19,202 shares in the company, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 0.53% of the company's stock.

Ventas Profile

Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source